TAYA IP | Tigermed

Integrated Capabilities

TAYA IP

Global Service Provider for Innovative IP Solutions

Tigermed Global IP Solutions

TAYA IP, a Tigermed Group company, is a global IP strategy team dedicated to empowering innovators. Built on expert translation, data intelligence, and worldwide networks, we deliver end-to-end lifecycle services—from portfolio strategy and overseas filing to European patent validation and annuity management.

Leveraging Tigermed’s deep clinical CRO expertise, we seamlessly align IP strategy with clinical development and regulatory milestones—reducing risks, optimizing asset value, and accelerating global commercialization.

Years

20+

Clients

500+

Countries

100+

Languages

Corpora

50M +

Services & Capabilities

Global Patent Translation
100+ languages, AI + expert double-check
Foreign Filing
Dual-channel (PCT/Paris Convention), localized strategy
European Validation
Traditional & Unitary Patent, end-to-end
Annuity Management
Global network, transparent pricing
Patent Consulting
Global strategy, data-driven
Patent Search
Landscape, FTO, novelty
Data Services
Competitive insights, asset optimization
TAYA Engine
Trained on massive corpora, customized terminology

Our Strengths
Tigermed Ecosystem Synergy：Multidisciplinary team proficient in clinical trials, regulatory submissions, and IP
Global Experience Backing Chinese Expansion：10+ years serving top global pharma, now empowering Chinese enterprises globally
Belt & Road and Emerging Markets：Covering SEA, Middle East, Latin America with localized IP strategies
Success Stories
Secured patent portfolios for leading innovators across China, US, and Europe
Provided IP support for successful FDA Breakthrough Device designation
End-to-end management from PCT national phase entry to European patent validation
Our Value
Empowering Chinese innovation with clear, robust, and enforceable global patent protection
Website：www.tayaip.com

Let's Connect for a Conversation